# Impact of Metabolic Disorders on cACLD Outcomes

> **NCT07534046** · — · NOT_YET_RECRUITING · sponsor: **The Second Affiliated Hospital of Chongqing Medical University** · enrollment: 4307 (estimated)

## Conditions studied

- Compensated Advanced Chronic Liver Disease

## Interventions

- **OTHER:** Observational Study

## Key facts

- **NCT ID:** NCT07534046
- **Lead sponsor:** The Second Affiliated Hospital of Chongqing Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04-01
- **Primary completion:** 2029-12-31
- **Final completion:** 2031-12-31
- **Target enrollment:** 4307 (ESTIMATED)
- **Last updated:** 2026-04-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07534046

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07534046, "Impact of Metabolic Disorders on cACLD Outcomes". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07534046. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*